BlackRock’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.14B | Buy |
30,599,409
+963,533
| +3% | +$49.9M | 0.03% | 427 |
|
|
2026
Q1 | $1.51B | Sell |
29,635,876
-2,869,857
| -9% | -$134M | 0.03% | 504 |
|
|
2025
Q4 | $959M | Buy |
32,505,733
+2,977,816
| +10% | +$80.9M | 0.02% | 703 |
|
|
2025
Q3 | $763M | Buy |
29,527,917
+916,447
| +3% | +$25.6M | 0.01% | 810 |
|
|
2025
Q2 | $789M | Buy |
28,611,470
+1,430,316
| +5% | +$37.7M | 0.02% | 753 |
|
|
2025
Q1 | $771M | Buy |
27,181,154
+1,389,207
| +5% | +$49.3M | 0.02% | 755 |
|
|
2024
Q4 | $1.07B | Buy |
25,791,947
+759,934
| +3% | +$36.3M | 0.02% | 601 |
|
|
2024
Q3 | $1.67B | Sell |
25,032,013
-530,308
| -2% | -$48.7M | 0.04% | 440 |
|
|
2024
Q2 | $3.04B | Buy |
25,562,321
+166,443
| +0.7% | +$21.1M | 0.07% | 249 |
|
|
2024
Q1 | $2.71B | Buy |
25,395,878
+94,186
| +0.4% | +$9.49M | 0.06% | 285 |
|
|
2023
Q4 | $2.52B | Buy |
25,301,692
+562,306
| +2% | +$47.3M | 0.06% | 285 |
|
|
2023
Q3 | $2.56B | Buy |
24,739,386
+575,675
| +2% | +$64.2M | 0.07% | 257 |
|
|
2023
Q2 | $2.94B | Sell |
24,163,711
-929,447
| -4% | -$124M | 0.08% | 238 |
|
|
2023
Q1 | $3.85B | Sell |
25,093,158
-1,022,645
| -4% | -$169M | 0.11% | 154 |
|
|
2022
Q4 | $4.69B | Buy |
26,115,803
+713,652
| +3% | +$117M | 0.15% | 121 |
|
|
2022
Q3 | $3B | Sell |
25,402,151
-815,231
| -3% | -$124M | 0.1% | 183 |
|
|
2022
Q2 | $3.75B | Sell |
26,217,382
-2,454,553
| -9% | -$351M | 0.12% | 152 |
|
|
2022
Q1 | $4.94B | Buy |
28,671,935
+1,010,462
| +4% | +$170M | 0.13% | 132 |
|
|
2021
Q4 | $7.03B | Buy |
27,661,473
+779,313
| +3% | +$228M | 0.18% | 95 |
|
|
2021
Q3 | $10.3B | Buy |
26,882,160
+7,491,435
| +39% | +$2.76B | 0.29% | 57 |
|
|
2021
Q2 | $4.56B | Sell |
19,390,725
-1,412,672
| -7% | -$252M | 0.13% | 137 |
|
|
2021
Q1 | $2.72B | Buy |
20,803,397
+326,683
| +2% | +$47.3M | 0.08% | 235 |
|
|
2020
Q4 | $2.14B | Buy |
20,476,714
+239,949
| +1% | +$24.3M | 0.07% | 282 |
|
|
2020
Q3 | $1.43B | Buy |
20,236,765
+412,616
| +2% | +$28.8M | 0.05% | 343 |
|
|
2020
Q2 | $1.27B | Buy |
19,824,149
+7,450,811
| +60% | +$408M | 0.05% | 356 |
|
|
2020
Q1 | $371M | Buy |
12,373,338
+649,320
| +6% | +$14.9M | 0.02% | 772 |
|
|
2019
Q4 | $229M | Buy |
11,724,018
+3,371,833
| +40% | +$59.8M | 0.01% | 1379 |
|
|
2019
Q3 | $133M | Buy |
8,352,185
+7,690,515
| +1,162% | +$114M | 0.01% | 1709 |
|
|
2019
Q2 | $9.69M | Buy |
661,670
+93,239
| +16% | +$2M | ﹤0.01% | 3271 |
|
|
2019
Q1 | $11.6M | Buy |
568,431
+542,793
| +2,117% | +$10.1M | ﹤0.01% | 3044 |
|
|
2018
Q4 | $391K | Buy |
+25,638
| New | +$421K | ﹤0.01% | 4115 |
|
Other funds holding MRNA
TP
BlackRock's MRNA Position: Q2 2026 in Review
BlackRock increased its Moderna (MRNA) stake by 3.3% in Q2 2026, buying an estimated $49.9M and bringing the position to 30,599,409 shares worth $2.14B. The position accounts for 0.03% of the portfolio, ranked #427.
BlackRock first reported a position in MRNA in Q4 2018 and has held it in 31 quarters since. The position peaked at $10.3B in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- BlackRock held 30,599,409 shares of Moderna worth $2.14B as of Q2 2026.
- BlackRock bought 963,533 Moderna shares in Q2 2026, an estimated $49.9M.
- Moderna made up 0.03% of BlackRock's portfolio in Q2 2026, its #427 holding.
- BlackRock first reported a position in Moderna in Q4 2018 and has held it in 31 quarters since.
- BlackRock's Moderna position peaked at $10.3B in Q3 2021.
- 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.